Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
FEMS Microbiol Lett ; 3712024 Jan 09.
Article in English | MEDLINE | ID: mdl-39076007

ABSTRACT

Pretreatment of lignocellulosic biomass produces growth inhibitory substances such as furfural which is toxic to microorganisms. Acinetobacter baylyi ADP1 cannot use furfural as a carbon source, instead it biotransforms this compound into difurfuryl ether using the reduced nicotinamide adenine dinucleotide (NADH)-dependent dehydrogenases AreB and FrmA during aerobic acetate catabolism. However, NADH consumption for furfural biotransformation compromises aerobic growth of A. baylyi ADP1. Depending on the growth phase, several genes related to acetate catabolism and oxidative phosphorylation changed their expression indicating that central metabolic pathways were affected by the presence of furfural. During the exponential growth phase, reactions involved in the formation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) (icd gene) and NADH (sfcA gene) were preferred when furfural was present. Therefore a higher NADH and NADPH production might support furfural biotransformation and biomass production, respectively. In contrast, in the stationary growth phase genes of the glyoxylate shunt were overexpressed probably to save carbon compounds for biomass formation, and only NADH regeneration was appreciated. Finally, disruption of the frmA or areB gene in A. baylyi ADP1 led to a decrease in growth adaptation and in the capacity to biotransform furfural. The characterization of this physiological behavior clarifies the impact of furfural in Acinetobacter metabolism.


Subject(s)
Acinetobacter , Furaldehyde , Acinetobacter/genetics , Acinetobacter/metabolism , Acinetobacter/drug effects , Acinetobacter/growth & development , Furaldehyde/metabolism , Furaldehyde/pharmacology , NAD/metabolism , Biotransformation , Gene Expression Regulation, Bacterial , NADP/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biomass , Metabolic Networks and Pathways/genetics
2.
Biotechnol Lett ; 43(5): 1043-1050, 2021 May.
Article in English | MEDLINE | ID: mdl-33590377

ABSTRACT

OBJECTIVES: To determine furfural biotransformation capabilities of Acinetobacter baylyi ADP1 and Acinetobacter schindleri ACE. RESULTS: Acinetobacter baylyi ADP1 and A. schindleri ACE could not use furfural as sole carbon source but when acetate was used as substrate, ADP1 and ACE biotransformed 1 g furfural/l in 5 and 9 h, respectively. In both cases, the product of this biotransformation was difurfuryl-ether as shown by FT-IR and 1H and 13C NMR spectroscopy. The presence of furfural decreased the specific growth rate in acetate by 27% in ADP1 and 53% in ACE. For both strains, the MIC of furfural was 1.25 g/l. Nonetheless, ADP1 biotransformed 2 g furfural/l at a rate of 1 g/l/h in the stationary phase of growth. A transcriptional analysis of possible dehydrogenases involved in this biotransformation, identified that the areB and frmA genes were highly overexpressed after the exposure of ADP1 to furfural. The products of these genes are a benzyl-alcohol dehydrogenase and an alcohol dehydrogenase. CONCLUSIONS: Acinetobacter baylyi ADP1 is a candidate for the biological detoxification of furfural, a fermentation inhibitor present in lignocellulosic hydrolysates, with the possible direct involvement of the AreB and FrmA enzymes in the process.


Subject(s)
Acinetobacter/metabolism , Furaldehyde/metabolism , Acetates/metabolism , Acinetobacter/drug effects , Acinetobacter/genetics , Acinetobacter/growth & development , Alcohol Oxidoreductases/genetics , Alcohol Oxidoreductases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biotransformation , Furaldehyde/pharmacology , Furans/metabolism , Furans/pharmacology , Gene Expression Regulation, Bacterial/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL